Close

Needham & Company Maintains an 'Underperform' on Immunogen (IMGN); Near-Term Value Creation Lacking Feb 28, 2011 08:02AM
Needham & Company Maintains an 'Underperform' on Immunogen (IMGN); Broad but Still Risky Plans for T-DM1 and Pipeline, Solid Cash Position, & Lack of 2011 Milestones Jan 28, 2011 10:58AM
Needham & Company Maintains an 'Underperform' on Immunogen (IMGN); T-DM1 Data Encouraging, Awaiting Further Data Updates to Pivotal Trial Jan 5, 2011 08:11AM
Needham & Company Initiates Coverage on ImmunoGen (IMGN) with an Underperform Nov 8, 2010 07:38AM
Morning Movers 4/16: PFWD, LGF, IMGN, PNK, BSX Higher; ABK, FHN, GOOG, AMD Lower Apr 16, 2010 10:05AM